Format
Sort by
Items per page

Send to

Choose Destination

Best matches for adenosine A1 receptor schizophrenia:

The adenosine neuromodulation system in schizophrenia. Rial D et al. Int Rev Neurobiol. (2014)

Adenosine receptor control of cognition in normal and disease. Chen JF et al. Int Rev Neurobiol. (2014)

Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia. Villar-Menéndez I et al. J Psychiatr Res. (2014)

Search results

Items: 1 to 20 of 23

1.

Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay.

Odagaki Y, Kinoshita M, Ota T, Meana JJ, Callado LF, Matsuoka I, García-Sevilla JA.

Purinergic Signal. 2018 Jun;14(2):177-190. doi: 10.1007/s11302-018-9603-x. Epub 2018 Feb 28.

PMID:
29492786
2.

Cell-subtype-specific changes in adenosine pathways in schizophrenia.

O'Donovan SM, Sullivan C, Koene R, Devine E, Hasselfeld K, Moody CL, McCullumsmith RE.

Neuropsychopharmacology. 2018 Jul;43(8):1667-1674. doi: 10.1038/s41386-018-0028-6. Epub 2018 Feb 26.

PMID:
29483661
3.

Purinergic receptors in psychiatric disorders.

Krügel U.

Neuropharmacology. 2016 May;104:212-25. doi: 10.1016/j.neuropharm.2015.10.032. Epub 2015 Oct 27. Review.

PMID:
26518371
4.

The adenosine neuromodulation system in schizophrenia.

Rial D, Lara DR, Cunha RA.

Int Rev Neurobiol. 2014;119:395-449. doi: 10.1016/B978-0-12-801022-8.00016-7. Review.

PMID:
25175974
5.

Adenosine receptor control of cognition in normal and disease.

Chen JF.

Int Rev Neurobiol. 2014;119:257-307. doi: 10.1016/B978-0-12-801022-8.00012-X. Review.

PMID:
25175970
6.

Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.

Villar-Menéndez I, Díaz-Sánchez S, Blanch M, Albasanz JL, Pereira-Veiga T, Monje A, Planchat LM, Ferrer I, Martín M, Barrachina M.

J Psychiatr Res. 2014 Apr;51:49-59. doi: 10.1016/j.jpsychires.2013.12.013. Epub 2014 Jan 7.

PMID:
24433848
7.

Modulators of nucleoside metabolism in the therapy of brain diseases.

Boison D.

Curr Top Med Chem. 2011;11(8):1068-86. Review.

8.

Adenosine and related drugs in brain diseases: present and future in clinical trials.

Lopes LV, Sebastião AM, Ribeiro JA.

Curr Top Med Chem. 2011;11(8):1087-101. Review.

PMID:
21401493
9.

Caffeine and adenosine.

Ribeiro JA, Sebastião AM.

J Alzheimers Dis. 2010;20 Suppl 1:S3-15. doi: 10.3233/JAD-2010-1379. Review.

PMID:
20164566
10.

Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population.

Gotoh L, Mitsuyasu H, Kobayashi Y, Oribe N, Takata A, Ninomiya H, Stanton VP Jr, Springett GM, Kawasaki H, Kanba S.

Psychiatr Genet. 2009 Dec;19(6):328-35. doi: 10.1097/YPG.0b013e3283328e26.

PMID:
19820430
11.

Caffeine-induced psychosis.

Hedges DW, Woon FL, Hoopes SP.

CNS Spectr. 2009 Mar;14(3):127-9.

PMID:
19407709
12.

Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.

Marek GJ.

Neuropharmacology. 2009 Jun;56(8):1082-7. doi: 10.1016/j.neuropharm.2009.03.005. Epub 2009 Mar 24.

13.

Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs.

Yee BK, Singer P, Chen JF, Feldon J, Boison D.

Eur J Neurosci. 2007 Dec;26(11):3237-52. Epub 2007 Nov 14.

PMID:
18005073
14.

Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.

Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF.

Physiol Behav. 2007 Sep 10;92(1-2):210-7. Epub 2007 May 21. Review.

PMID:
17572452
15.

Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications.

Lara DR, Dall'Igna OP, Ghisolfi ES, Brunstein MG.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):617-29. Epub 2006 Mar 6. Review.

PMID:
16580767
16.
18.

Functions of neuronal adenosine receptors.

Haas HL, Selbach O.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):375-81. Review.

PMID:
11111831
19.
20.

Supplemental Content

Loading ...
Support Center